Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.83+0.03 (+0.15%)
Close on Nov 13, 2026Market cap $936.90MP/E –Yield –
Silence Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Silence Therapeutics's operating margin for the twelve months ending Sep 30, 2026 was -12343.6%. For fiscal 2025 it was -16292.8%, against -146.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -16292.8% | −16146.5 |
| FY2024 | Dec 31, 2024 | -146.4% | +57.1 |
| FY2023 | Dec 31, 2023 | -203.5% | +78.4 |
| FY2022 | Dec 31, 2022 | -281.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -3729.1% | +16277.2 |
| Q4 FY2025 | Dec 31, 2025 | -36650.0% | −36632.8 |
| Q3 FY2025 | Sep 30, 2025 | -16505.7% | −14503.2 |
| Q2 FY2025 | Jun 30, 2025 | -10697.8% | −7604.1 |
| Q1 FY2025 | Mar 31, 2025 | -20006.3% | −19970.8 |
| Q4 FY2024 | Dec 31, 2024 | -17.2% | – |
| Q3 FY2024 | Sep 30, 2024 | -2002.5% | – |
| Q2 FY2024 | Jun 30, 2024 | -3093.7% | – |
| Q1 FY2024 | Mar 31, 2024 | -35.6% | – |
See a number that looks wrong?